Skip to main content
Equibles

Dr. Joshua Ofman

CEO

GRAIL, Inc. (GRAL)

Equibles does not estimate personal net worth.

Get an email with a short summary when GRAIL, Inc. publishes a filing, an earnings call transcript or a press release.

Get GRAL alerts

About Dr. Joshua Ofman

Dr. Joshua Ofman is recorded as CEO at GRAIL, Inc. (GRAL) since June 1, 2026. GRAIL, Inc. reported in an 8-K filed June 1, 2026 that Dr. Joshua Ofman was appointed Chief Executive Officer, effective June 1, 2026. Dr. Joshua Ofman has spoken on 1 earnings call across 1 company, most recently for GRAIL, Inc. on August 5, 2026. GRAIL, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GRAIL, Inc. includes Joshua Ofman (CEO and Board Member), Robert P. Ragusa (CEO and Board Member), Robert Ragusa (CEO and Board Member) and 7 others.

“In connection with Dr. Joshua Ofman's appointment as the Chief Executive Officer of GRAIL, Inc. (the "Company"), on June 1, 2026, the Company's board of directors (the "Board") approved an amended and restated offer letter (the "Amended Offer Letter") and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the "Effective Date").”
GRAIL, Inc. Form 8-K, filed June 1, 2026 · Read the filing

Dr. Joshua Ofman on recent calls

“We launched a gallery test in 2021 after our approximate 6,000 participant interventional Pathfinder study, which was conducted under an FDA-approved investigational device exemption and read out and demonstrated strong performance and safety in a screening population.”
CEO, GRAIL, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at GRAIL, Inc.

Recent activity